Annexin V staining (green) represents the cells undergoing apoptosis and propidium iodide (reddish) represents cells in late apoptosis. Wnt target genes. Most importantly, lupeol restricted the translocation of -catenin from your cytoplasm to the nucleus. Lupeol also decreased the growth of Mel 928 but not Mel 1011-derived tumors implanted in the athymic nude mice. The decrease in Mel 928-derived tumor growth was associated with a decrease in the expression of Wnt target genes c-myc, cyclin D1, proliferation markers proliferating cell nuclear antigen and Ki-67 and invasion marker osteopontin. We suggest that lupeol alone or as an adjuvant to current therapies could be developed as an agent for the management of human melanomas harboring constitutive Wnt/-catenin signaling. == Introduction == Melanoma, the most serious form of skin cancer, is usually curable in its initial stages but when detected at later stages, is one of the most lethal malignancies (1,2). The increasing incidence of melanoma and its poor prognosis advocates the need for the development of Eriodictyol novel preventive approaches such as the use of specific targeting agents Eriodictyol derived from natural products (3). Lupeol [Lup-20(29)-en-3-ol], a dietary triterpene, found in various fruits, vegetables and some medicinal herbs (48) has been shown to possess strong anti-inflammatory, anticarcinogenic, anti-mutagenic and anti-malarial activity bothin vitroandin vivo(5,7,915). Our recent studies have also shown that lupeol possesses Eriodictyol chemopreventive effects in a two-stage mouse skin carcinogenesis model (16). Wnt/-catenin signaling pathway is usually reported to play an important role Eriodictyol in embryogenesis, stem cell maintenance and tumorigenesis, including melanoma progression (1719). -catenin is usually a key component of the Wnt signaling pathway Rabbit polyclonal to YY2.The YY1 transcription factor, also known as NF-E1 (human) and Delta or UCRBP (mouse) is ofinterest due to its diverse effects on a wide variety of target genes. YY1 is broadly expressed in awide range of cell types and contains four C-terminal zinc finger motifs of the Cys-Cys-His-Histype and an unusual set of structural motifs at its N-terminal. It binds to downstream elements inseveral vertebrate ribosomal protein genes, where it apparently acts positively to stimulatetranscription and can act either negatively or positively in the context of the immunoglobulin k 3enhancer and immunoglobulin heavy-chain E1 site as well as the P5 promoter of theadeno-associated virus. It thus appears that YY1 is a bifunctional protein, capable of functioning asan activator in some transcriptional control elements and a repressor in others. YY2, a ubiquitouslyexpressed homologue of YY1, can bind to and regulate some promoters known to be controlled byYY1. YY2 contains both transcriptional repression and activation functions, but its exact functionsare still unknown and its translocation to the nucleus initiates transcription of downstream target genes (20). Overexpression of Wnt ligands, mutations in components of Wnt pathway and stabilization of -catenin are the most common alterations associated with constitutive activation of Wnt signaling pathway and are observed in a variety of cancers including melanomas. Melanoma cells exhibit differential -catenin expression with Mel 1241 cell line transporting a stabilizing mutation of -catenin, whereas Mel 928 expresses wild-type -catenin without detectable adenomatosis polyposis coli (APC). Mel 1011 cells harbor both intact -catenin and APC. Mel 928 and Mel 1241 cells are also characterized by nuclear localization of -catenin and constitutive activation of -catenin/Tcf-dependent transcription (21,22). It is noteworthy that the hallmark of active Wnt signaling, nuclear localization of -catenin, has been observed in about a third of main and metastatic human melanomas (21,23). Recently, we exhibited that lupeol inhibits the growth of metastatic melanoma cellsin vitroandin vivo(24). While defining the mechanism of these inhibitory effects of lupeol on melanoma cells, we made a novel observation that it specifically targets melanoma cells that harbor constitutive Wnt/-catenin signaling pathway. This information coupled with our previously published data (24), which exhibited that lupeol exerts negligible toxicity on normal human melanocytes, advocates that lupeol could be developed as a potential agent for the management of Eriodictyol melanomas that harbor constitutive Wnt/-catenin signaling pathway. == Materials and methods == == Materials == The plasmids dominant-negative T-cell factor (TCF) 4, -cateninS33Y, pcDNA and TOP-Flash reporter plasmid bearing the TCF4-binding sequence were obtained from Drs K.Kinzler and B.Vogelstein (2528), whereas pTK-puro plasmid was obtained from Addgene (Cambridge, MA). Renilla luciferase (pRL-TK) plasmid was obtained from Promega (Madison, WI). Precast 12% Tris-glycine polyacrylamide gels were obtained from Invitrogen (Carlsbad, CA). Antibodies against proliferating cell nuclear antigen (PCNA), Ki-67, osteopontin, -catenin, vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP) 2/9 antibodies that detect activated proteins were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies against -actin, cyclin D1, c-myc were procured from Sigma (St Louis, MO), Cell Signaling Technology (Danvers, MA) and BD Biosciences Pharmingen (San Jose, CA), respectively. Pathscan ELISA kit for -catenin was obtained from Cell Signaling Technology. == Cell lines and cell culture == The melanoma cell lines Mel 928, Mel 1241 and Mel 1011 were.